FDA
-
-
-
-
-
-
-
Sernova Biotherapeutics Submits IND Application for its Cell Pouch Bio-Hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism
-
-
-
-
-
-
-
Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Glucose Monitoring Systems
-
-
333,560 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


